siRNA treatment lowers triglycerides in patients with rare health condition

.RESEARCH STUDY FEATURE.19 September 2024.

Plozasiran reduced triglyceride amounts by 80% as well as decreased the threat of pancreatitis in clients with relentless chylomicronemia, along with or without a hereditary medical diagnosis.